The development of high-throughput crystallography combined with the wealth of already accumulated information about protein crystallization properties requires constant revision of current crystallization screening procedures. Two complementary 6 Â 4 matrix`clear strategy screens' (CSS) have been developed and tested on a number of previously non-crystallized proteins. The screens yielded diffraction-quality crystals of a wide range of proteins (enzymes, transcription factors, structural proteins, etc.) in cases where the applications of commercially available screens were unsuccessful. Both their inherently simple design and their¯exible nature provide an experimenter with a logical platform for further modi®cation and optimization. Furthermore, the screens facilitate cryoprotection and potential incorporation of anomalous scatterers for multiple/ single-wavelength anomalous dispersion (MAD/SAD) experiments.
Introduction
Despite considerable progress in the ®eld of crystallogenesis, protein crystallization for macromolecular crystallography still presents a considerable challenge. In recent years, many procedures have been developed in an endeavour to rationalize the trial-and-error character of protein crystallization, resulting in several commercial or public-domain 1 crystallization screens (e.g. Jancarick & Kim, 1991; Stura et al., 1992; Cudney et al., 1994; Zeelen et al., 1994; Lloyd, 1996; Garman & Mitchell, 1996; Bergfors et al., 1999 ; Hampton Research, USA; Molecular Dimensions, UK; Emerald BioStructures Inc., USA). The underlying principles of these screens were initially based on assumptions about the equal probability of the parameter space for crystallization conditions (Carter & Carter, 1979) . Compositions of the screens evolved gradually on the basis of current published results, the increasing information content of the Biological Macromolecular Crystallization Database (BMCD) (Gilliland et al., 1994) and a substantial element of the subjective experience of their creators. Further stages of this rationalization were re¯ected in works by Samudzi et al. (1992) , Hennessy et al. (1994) and recently by Hennessy et al. (2000) , who have tried to derive better probability distributions as the basis for optimizing search procedures for a particular macromolecule. This approach is based on the common belief that particular classes of macromolecules (e.g. enzymes, chaperonins, heme proteins, virus capsids and their components, IgGs, tRNA synthethases) exhibit common patterns of crystallization (Hennessy et al., 2000) . Although the protein classi®cations for this purpose are still very inadequate and approximate, tailoring the design of crystallization experiments according to the character of the protein may become more important in the era of structural/ functional genomics, for which the protein supply may often be very limited and hence fewer crystallization trials may be performed.
Our vision of the crystallization approach, partially re¯ected in the formulation of the`clear strategy screens' presented here, is very much in accordance with other trends towards rationalization of the crystallogenesis process. The minimalist nature of our screening procedures originates from several rather simple observations, as follows.
(a) There is frequently a common trend in the crystallization pathways of chemically or structurally similar groups of macromolecules (see e.g. Hennessy et al., 2000) .
(b) The available screens may increase unnecessarily the number of trials that in the case of a particularly well characterized macromolecule could be truncated to a dozen relatively well known conditions.
(c) In most cases, crystallization conditions remain, even for membrane proteins, multi-protein complexes, protein/DNA complexes, etc., relatively simple, meaning that there is no real need for the plethora of`new' conditions.
(d) The rationales behind the formulation of most commercially available screens are not very transparent for less experienced experimenters, not providing enough data for further experiments when they lead to widespread precipitation or no crystals.
(e) In our opinion, the basic prerequisite for successful crystallization lies in the control of the folding homogeneity of a particular macromolecule, which is frequently not correlated with its chemical purity. Thus the main emphasis in the crys-tallogenesis process should be shifted from the often technically trivial process of crystallization towards a more comprehensive characterization of the macromolecule under investigation.
Considering these observations, the`clear strategy screens' proposed here are obviously not intended to represent aǹ ultimate' tool for macromolecule crystallization, but should suggest instead more individual and alternative approaches to crystallization problems.
Materials and methods
All tests of the two`clear strategy screens' CSS-I and CSS-II have been carried out using proteins from on-going in-house research projects [of the York Structural Biology Laboratory (YSBL)]. None of these proteins/complexes has been crystallized before. Details of the quality of the crystals, space groups, protein structures, etc., will be described by the individual research groups concerned in subsequent publications. Dynamic light scattering (DLS), with the use of the DynaPro Instrument (ProteinSolutions), was systematically employed to control the potential aggregation properties of all the test proteins reported here.
Polyethylene glycols (PEGs) and Jeffamine were purchased from Fluka. All other chemicals were purchased from Sigma. PEG concentrations are expressed as w/v %. The CSS stock solutions were made up to 90% volume, leaving the remaining volume for the buffer of choice to be added later during the crystallization setup. The highly basic Jeffamine solution was buffered to pH 7.5 prior to further use. Typically, the CSS-I/II conditions were applied at their stated compositions but, in cases of either poor solubility or where target proteins were prone to aggregation, dilutions of 0.6 or 0.8 were evaluated as well. The hanging-drop method was used for all crystallizations, which were carried out at 291 K, in 24-well Linbro tissue culture plates. The quality of the diffraction of the resulting crystals was checked on MAR Research image-plate systems with a Cu rotating-anode Rigaku RU200 generator equipped with mirror optics (Yale/Molecular Structure Corporation and Osmic mirrors). All X-ray experiments were performed on¯ash-cooled crystals at 120 K.
Results and discussion
3.1. Clear strategy screen I CSS-I was designed as the ®rst of two screens (see Fig. 1 ) with the following principles in mind.
3.1.1. Enzymatic proteins as main targets. One of the main principles behind the formulation of this screen was to increase the rate of successful crystallization of one particular group of macromolecules, namely enzymes, which are the most widely studied proteins in our laboratory. The use of PEG or salt is rather common in the crystallization of enzymes. The ®nal formulations of the screen solutions re¯ect our personal experience (see e.g. Brzozowski, 1993; Brzozowski & Tolley, 1994) but are also greatly in¯uenced by published results. The other main aim of the CSS-I was to decrease the number of screening conditions, which is re¯ected in the small 6 Â 4 matrix, so as to permit initial trials when a limited amount of protein is available. Well diffracting crystals of several enzymatic proteins, such as penicillin acylase, acetyltransferases, endoglucanases, lipases and isomerase, have been obtained (see Table 1 ). Typically, parallel trials with other screens, such as Hampton Crystal Screen and Crystal Screen 2, failed to give crystals for these proteins. Furthermore, CSS-I also proved to be useful for nonenzymatic proteins, yielding crystals of several nuclear receptor complexes, of protein involved in the process of bacterial sporulation, of fragments of ®brinogen and of growth factors. Crystals of a given protein were often obtained simultaneously under several different conditions. Most of the crystals obtained under the screen conditions were of good diffraction quality and, when needed, optimization involved only slight alterations in protein or precipitant concentrations.
3.1.2. Full control of the pH of the screen solutions. The pH of the crystallization solution is one of the most important parameters in the crystallization process. The formulation of both screens, CSS-I and CSS-II, at 90% of their ®nal volumes leaves the choice of the pH of the screen up to the user. Typically, the pH of 0.9 ml of the screen solution was adjusted by the addition of 0.1 ml of 1 M stock buffer. The chosen starting pH depended on prior knowledge of the properties of each protein, such as puri®cation characteristics, isoelectric point, solubility/stability, pH-aggregation dependence estimated by DLS, previous crystallization experience with related proteins, etc. If the optimum pH was unclear, cacodylate buffer at pH 6.5 was used as a ®rst choice. This buffer system covers a broad plateau of the pK a values of individual amino acids and also provides an additional protection against potential speci®c protein aggregation caused by free ±SH groups (see e.g. Wagner et al., 1995) . In summary, our experience with CSS-I shows that the rational use of pH can accelerate successful crystallogenesis through the minimum number of trials.
3.1.3. Cryoprotection of the crystals. The simple but ef®-cient 6 Â 4 matrix of the screen was designed with some builtin provision for the straightforward cryoprotection of any resultant crystals. Crystals obtained with PEGs of 2000 and 4000 molecular weight may be cryoprotected using the same PEGs at higher concentrations ($30±35% w/v). Potential cryoprotection of crystals grown with PEG 8000 and PEG 20000 has been facilitated by the introduction of additional PEGs of smaller molecular weights. Both PEG 1000 and PEG 550 MME are good cryoprotectants at higher concentrations.
3.1.4. Rational planning of further experiments. One of the main aims of the CSS-I formulation is that its underlying principles should be very transparent to the user. A simple matrix of different PEGs versus different salts, combined with simultaneous control of the pH, enables both easy interpretation of results and planning of the next experiments. Despite the limited number of starting parameters, their logical extension towards a new set of conditions can be easily achieved by an increase in the salt or PEG concentration, a shift towards one of the two mixed PEGs, or even a change of the pH.
Provision of potential anomalous scattering centres.
The coupling of new crystallization screens with modern methods to solve the crystallographic phase problem is of special importance for high-throughput crystallography. One of the easiest ways to implement this idea was shown in the very exciting work of Dauter et al. (2000) . Five protein structures were solved by utilizing only the anomalous signals from bromide and iodide anions incorporated into the protein crystals by soaking quickly in the Br-or I-containing cryoprotectants. To increase the chance of the application of this important approach, one set of the CSS-I conditions includes potassium bromide. Several well diffracting crystals have been obtained from these conditions and we are currently evaluating whether initial phase estimates can be obtained through location of anomalous scatterer sites.
Clear strategy screen II
Although CSS-I has wide applications, we felt the need to develop a complementary 6 Â 4 set of conditions to ®ll the gaps in the network of crystallization parameters. The basic principles of CSS-I described above in xx3.1.1±3.1.5 were also applied to CSS-II (see Fig. 1 ). Its two-dimensional layout is very simple and can be divided into several integral areas (A± E). Conditions 1±4 and 7±10 (area A) represent single salt screening to provide additional information about protein solubility. Each salt is represented by two conditions, thus giving clearer insight into protein/salt solubility dependence, while at the same time minimizing the risk of overlooking a positive condition in cases where only one (e.g. heavily precipitating) salt concentration is applied. Conditions 13±14 and 19±20 (area B) function as an`organic' solution screen, and conditions 15 and 21 (area C) evaluate the in¯uence of heavier cations on protein crystallization properties. Section D of CSS-II, formed by conditions 16±18 and 22±24, supplements CSS-I with other PEGs, mixed with KSCN (our favourite chaotrope salt). The last corner of CSS-II (area E), represented by the conditions 5±6 and 11±12, remains for us à creativity corner', symbolizing part of the screening matrix that can be biased towards the user's favourite conditions. In our case, it combines PEG 4000, probably the most widely used polymer, together with calcium acetate, a rather common salt in protein crystallization, which is not represented in CSS-I.
CSS-II, contrary to the more rigidly and precisely de®ned CSS-I, gives each individual investigator a wide range of tools and parameters to re¯ect both his/her personal experience and the speci®city of the project. For example, conditions 1±2, 4, 7± 8 and 10 should not be used if calcium is required for the protein activity or integrity; instead they may be replaced by other salts that do not crystallize as easily in the presence of Ca 2+ ; Cd 2+ and Ni 2+ may be replaced by cations more speci®c for a particular protein (e.g. Zn 2+ , Cu
2+
, Mn 2+ , etc.) or even by heavy metals such as Hg or U, albeit at much lower (1±2 mM) concentrations; calcium acetate (conditions 5±6, 11±12) may also be replaced by another salt if necessary. CSS-II should therefore be considered as a¯exible scaffolding of parameters that can be easily modi®ed by the individual user, but preferably, in the context of conditions available in CSS-I.
Conclusions
Although driven by slightly different principles, CSS-I and CSS-II should be seen as self-complementary screens, which may, at least in our experience, be used instead of other screens, such as Hampton Research Crystal Screens 1 and 2, thereby halving the number of initial trials required. However, our main goal is not to put CSS-I and CSS-II forward as yet another pair of alternative screening kits, but by highlighting their simplicity and ef®ciency, to underline the urgent need for Table 1 Examples of some proteins crystallized by CSS-I/II but not by Hampton Crystal Screens 1 and 2.
The successful condition and maximum resolution of diffraction are given where appropriate permission to reproduce such data has been obtained. Detailed crystallographic data will be published elsewhere. Abbreviations: C 8 E 5 , polyoxyethylene 5-octyl ether; C 10 E 3 , polyoxyethylene 3-decyl ether; di-C12-POC, didodecyl phosphatidyl choline; Tris, tris(hydroxymethyl)aminomethane.
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